ZD1839 (‘Iressa’), a Specific Oral Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor, Potentiates Radiotherapy in a Human Colorectal Cancer Xenograft Model
British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6600182
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2002
Authors
Publisher
Springer Science and Business Media LLC